Revenues Beat Expectations, EPS Lags

Plant Health Care (LON:PHC) Full Year 2022 Results

Key Financial Results

  • Revenue: US$11.8m (up 40% from FY 2021).

  • Net loss: US$9.48m (loss widened by 50% from FY 2021).

  • US$0.03 loss per share (further deteriorated from US$0.022 loss in FY 2021).



All figures shown in the chart above are for the trailing 12 month (TTM) period

Plant Health Care Revenues Beat Expectations, EPS Falls Short

Revenue analysts exceeded estimates by 3.2%. Earnings per share (EPS) analyst missed estimates by 150%.

Looking ahead, revenue is forecast to grow 37% pa on average over the next 2 years, compared to a 2.3% growth forecast for the Chemicals industry in the United Kingdom.

Performance of the British Chemicals industry.

The company’s shares are down 11% from a week ago.

Risk Analysis

Don’t forget that there may still be risks. For instance, we’ve identified 1 warning sign for Plant Health Care that you should be aware of.

Have feedback on this article? Concerned about the content? get in touch with us directly. Alternatively, email editorial-team (at)

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Join A Paid User Research Session
You’ll receive a US$30 Amazon Gift Card for 1 hour of your time while helping us build better investing tools for the individual investors like yourself. Sign up here

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top